BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yu ZW, Zhao P, Liu M, Dong XS, Tao J, Yao XQ, Yin XH, Li Y, Fu SB. Reversal of 5-flouroucial resistance by adenovirus-mediated transfer of wild-type p53 gene in multidrug-resiatant human colon carcinoma LoVo/5-FU cells. World J Gastroenterol 2004; 10(13): 1979-1983 [PMID: 15222051 DOI: 10.3748/wjg.v10.i13.1979]
URL: https://www.wjgnet.com/1007-9327/full/v10/i13/1979.htm
Number Citing Articles
1
Jose J.G. Marin, Rocio I.R. Macias, Maria J. Monte, Elisa Herraez, Ana Peleteiro-Vigil, Beatriz Sanchez de Blas, Paula Sanchon-Sanchez, Alvaro G. Temprano, Ricardo A. Espinosa-Escudero, Elisa Lozano, Oscar Briz, Marta R. Romero. Cellular Mechanisms Accounting for the Refractoriness of Colorectal Carcinoma to Pharmacological TreatmentCancers 2020; 12(9): 2605 doi: 10.3390/cancers12092605
2
Teng Wang, Zhen Chen, Yifei Zhu, Qiongxi Pan, Yanjun Liu, Xiaowei Qi, Linfang Jin, Jian Jin, Xin Ma, Dong Hua. Inhibition of Transient Receptor Potential Channel 5 Reverses 5-Fluorouracil Resistance in Human Colorectal Cancer CellsJournal of Biological Chemistry 2015; 290(1): 448 doi: 10.1074/jbc.M114.590364
3
Ning Zhang, Ying Yin, Sheng-Jie Xu, Wei-Shan Chen. 5-Fluorouracil: Mechanisms of Resistance and Reversal StrategiesMolecules 2008; 13(8): 1551 doi: 10.3390/molecules13081551
4
Onat Kadioglu, Mohamed E M Saeed, Markus Munder, Andreas Spuller, Henry Johannes Greten, Thomas Efferth. Effect of ABC transporter expression and mutational status on survival rates of cancer patientsBiomedicine & Pharmacotherapy 2020; 131: 110718 doi: 10.1016/j.biopha.2020.110718
5
Farid E Ahmed. Molecular markers that predict response to colon cancer therapyExpert Review of Molecular Diagnostics 2005; 5(3): 353 doi: 10.1586/14737159.5.3.353
6
DONGMEI YAN, XIAOLIANG ZHENG, LINGLAN TU, JING JIA, QIN LI, LIYAN CHENG, XIAOJU WANG. Knockdown of Merm1/Wbscr22 attenuates sensitivity of H460 non-small cell lung cancer cells to SN-38 and 5-FU without alteration to p53 expression levelsMolecular Medicine Reports 2015; 11(1): 295 doi: 10.3892/mmr.2014.2764
7
Yong Ji, Jian Lv, Di Sun, Yufeng Huang. Therapeutic strategies targeting Wnt/β‑catenin signaling for colorectal cancer (Review)International Journal of Molecular Medicine 2021; 49(1) doi: 10.3892/ijmm.2021.5056
8
JINGHAN WANG, YONG YU, ZI YAN, ZHENLI HU, LINFANG LI, JIANG LI, XIAOQING JIANG, QIJUN QIAN. Anticancer activity of oncolytic adenoviruses carrying p53 is augmented by 11R in gallbladder cancer cell lines in vitro and in vivoOncology Reports 2013; 30(2): 833 doi: 10.3892/or.2013.2511
9
Richard Hummel, David I. Watson, Cameron Smith, Jakob Kist, Michael Z. Michael, Joerg Haier, Damian J. Hussey. Mir-148a Improves Response to Chemotherapy in Sensitive and Resistant Oesophageal Adenocarcinoma and Squamous Cell Carcinoma CellsJournal of Gastrointestinal Surgery 2011; 15(3): 429 doi: 10.1007/s11605-011-1418-9
10
Xiangbai Wu, Yongzhi Deng, Guobin Wang, Kaixiong Tao. Combining siRNAs at Two Different Sites in the EGFR to Suppress its Expression, Induce Apoptosis, and Enhance 5-Fluorouracil Sensitivity of Colon Cancer CellsJournal of Surgical Research 2007; 138(1): 56 doi: 10.1016/j.jss.2006.06.027
11
Qi Xie, Bi-Ling Liang, Yan-Heng Wu, Jing Zhang, Ming-Wang Chen, Hong-Yan Liu, Xiong-Fei Gu, Jin Xu. Synergistic anticancer effect of rAd/P53 combined with 5-fluorouracil or iodized oil in the early therapeutic response of human colon cancer in vivoGene 2012; 499(2): 303 doi: 10.1016/j.gene.2012.02.007
12
Fernando M. Simabuco, Mirian G. Morale, Isadora C.B. Pavan, Ana P. Morelli, Fernando R. Silva, Rodrigo E. Tamura. p53 and metabolism: from mechanism to therapeuticsOncotarget 2018; 9(34): 23780 doi: 10.18632/oncotarget.25267
13
Jose J.G. Marin, Rocio I.R. Macias, Elisa Herraez, Elisa Lozano, Marta R. Romero, Silvia Di Giacomo, Thomas Efferth, Oscar Briz. Drug Efflux Pumps in Cancer Resistance Pathways: From Molecular Recognition and Characterization to Possible Inhibition Strategies in Chemotherapy2020; : 197 doi: 10.1016/B978-0-12-816434-1.00007-3
14
Jose J. G. Marin, Rocio I. R. Macias, Maitane Asensio, Marta R. Romero, Alvaro G. Temprano, Olívia R. Pereira, Silvia Jimenez, Jose L. Mauriz, Silvia Di Giacomo, Matias A. Avila, Thomas Efferth, Oscar Briz. Strategies to enhance the response of liver cancer to pharmacological treatmentsAmerican Journal of Physiology-Cell Physiology 2024; 327(1): C11 doi: 10.1152/ajpcell.00176.2024